There have been many advancements and changes in the way clinical trials are conducted—especially in the COVID-19 era. Watch Jamie Macdonald, CEO, and Sy Pretorius, MD, President, Clinical Development
Watch Video
Decentralized clinical trials (DCTs) are here to stay and we have learned many lessons about them through the COVID-19 pandemic. Watch part 1 of our ‘Practically Speaking’ video series where Jenny Gi
Watch Video
The COVID-19 pandemic shined a spotlight on the importance of clinical research to the success of the biotech industry’s drive to bring new therapies to market safely and efficiently. In this fireside
Watch Video
The biotech industry posted record financing, deals, and M&A numbers in 2020 and 2021, spurred in part by the swift and successful development of COVID-19 vaccines. Despite this favorable funding...
Read Article
In the United States, the FDA and CDC recently granted emergency use authorization (EUA) for Pfizer’s COVID-19 vaccine for 5–11-year-olds, making it the first COVID-19 vaccine available for...
Read Article
COVID-19 led to an era of remarkable regulatory flexibility and innovation with Decentralized Clinical Trial (DCT) strategies and tools but are they here to stay? Read more in this article.
Read Flipbook
Read Flipbook
Read Flipbook
Read Article
In this whitepaper, we address the unique variables, optimal timing, and immunogenic considerations for vaccinating individuals with cancer.
Read Flipbook
Read Article
Learn more from Roz Round, Parexel’s Vice President, Patient Innovation Center about how Decentralized Clinical Trials can help ensure patient safety and enable ongoing trial participation.
Read Flipbook
About the Authors Aaron Dy, Ph.D. is a Senior Analyst in the Health Advances...
Read Article
About the Authors Steven Chang, Ph.D. is a Senior Analyst in the Health...
Read Article
Since the COVID-19 pandemic began in early 2020, the Center for Drug Evaluation (CDE) has maximized its capacity and optimized its regulatory procedures within the SAP framework to accelerate...
Read Article
The regulatory pathway for COVID-19 drugs in China is governed by the Special Approval Program (SAP) which was introduced by National Medical Product Administration (NMPA) in 2005. SAP is...
Read Article
Conducting clinical trials during the COVID-19 pandemic has produced many challenges globally. The initiation, conduct, implementation and completion of a trial during this time requires special...
Read Article
Conducting clinical trials during the COVID-19 pandemic has produced many challenges globally. The initiation, conduct, implementation and completion of a trial during this time requires special...
Read Article
Key Takeaways The COVID-19 pandemic has drawn attention to international efforts to promote...
Read Article
With the continued threat of COVID-19, the way inspections will be performed and hosted will be significantly different from the pre-pandemic situation.
Read Article
Loading More...
